How Does Wegovy Compare to Other Weight Loss Medications?

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide injection) became widely known after its 2021 FDA approval, but it's one of several medications in the GLP-1 class that work by slowing digestion and reducing hunger signals in the brain. Clinical trials show that GLP-1 receptor agonists can produce weight loss of 15–22% of body weight over 68 weeks when combined with lifestyle changes. PlexusDx offers access to compounded semaglutide and other evidence-based weight loss medications without insurance barriers, at $189/mo month-to-month, or from $149/mo on the 6-month plan.

Understanding GLP-1 Medications and Their Mechanisms

GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone that regulates blood sugar, slows gastric emptying, and signals fullness to the brain. Medications that mimic GLP-1 work by activating GLP-1 receptors in the hypothalamus and gastrointestinal tract, which decreases appetite and increases satiety. This class includes brand-name drugs like Wegovy and Ozempic, as well as compounded formulations produced by licensed 503A compounding pharmacies.

The difference between brand-name and compounded GLP-1 medications lies primarily in manufacturing, distribution, and cost—not mechanism of action. Both use the same active pharmaceutical ingredients and are subject to pharmacopeial standards for purity and potency. Compounded semaglutide from PlexusDx delivers the same receptor activation and metabolic effects as Wegovy, making it a clinically equivalent option for many patients seeking affordability and accessibility.

Semaglutide vs. Tirzepatide: Key Differences

Semaglutide activates only the GLP-1 receptor, while tirzepatide is a dual GLP-1/GIP receptor agonist. In the SURMOUNT clinical trial, tirzepatide produced greater average weight loss (up to 22.5% of body weight) compared to semaglutide (up to 17.5% at the highest tested dose). However, individual response varies significantly based on genetics, lifestyle, and metabolic factors—some patients achieve excellent results on semaglutide alone.

PlexusDx offers both options: compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan. Patients interested in comparing both mechanisms without committing to one medication can use the PlexusDx Precision Peptide Genetic Test ($298) to identify genetic predispositions across GIPR and FTO, and MC4R pathways—insights that help optimize medication selection.

Compounded vs. Brand-Name Weight Loss Drugs

Brand-name medications like Wegovy and Mounjaro carry higher price tags due to pharmaceutical company manufacturing, marketing, and distribution costs. A month's supply of Wegovy can cost $900–$1,500 without insurance, while PlexusDx compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide at $289 per month. Both are eligible for HSA and FSA accounts, and PlexusDx serves all 50 states without requiring insurance or a membership fee.

Compounded formulations are produced in licensed 503A compounding pharmacies, which follow strict quality and safety standards set by the United States Pharmacopeia and state pharmacy boards. The active ingredients are identical to brand formulations, and compounding allows for dose flexibility and customization that benefits patients who need fine-tuning during their treatment journey.

Cost, Access, and Personalization at PlexusDx

PlexusDx eliminates common barriers to GLP-1 therapy: no insurance requirement, no membership fee, no copay games, and transparent pricing that doesn't change as your dose increases. Compounded semaglutide injection, oral semaglutide, tirzepatide injection, and oral tirzepatide are each priced at a single monthly rate across three commitment tiers. Patients can also choose the microdose GLP-1 protocol at $129 per month for those seeking a lower-intensity starting point, or the GLP-Squared dual-compound option for those wanting both GLP-1 and GIP receptor activation from the start.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as Wegovy?

Yes. Compounded semaglutide and Wegovy contain identical active ingredients and activate the same GLP-1 receptors in the brain and gut. Clinical outcomes depend on individual genetics, dose titration, and adherence—not whether the medication is brand-name or compounded. PlexusDx compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan and delivers the same weight loss mechanism.

What does the PlexusDx Precision Peptide Genetic Test show?

The test analyzes variants in 14 metabolic pathways across 49 peptides, including GIPR, FTO, and MC4R genes. Results reveal your genetic predisposition to GLP-1 receptor sensitivity, hunger hormone signaling, and weight regulation—helping determine whether semaglutide, tirzepatide, or a dual compound (GLP-Squared) is likely optimal for your biology. The test is $298.

Can I switch from Wegovy to PlexusDx compounded semaglutide?

Yes. If you're already taking Wegovy and want to switch to compounded semaglutide for cost savings, PlexusDx can work with your prescriber to transition you. You'll maintain the same dose and mechanism of action while reducing your monthly cost from $900+ to $149. PlexusDx serves all 50 states and requires no insurance.

What are the side effects of semaglutide and tirzepatide?

Common side effects include nausea, vomiting, constipation, and diarrhea—especially during dose escalation in the first 4–8 weeks. These typically resolve as your body adapts. Tirzepatide may have a slightly higher incidence of nausea due to dual receptor activation, but clinical trials show tolerability improves over time. Report severe or persistent symptoms to your PlexusDx provider immediately.

How does PlexusDx pricing compare to insurance copays?

PlexusDx flat pricing ($189–$289/mo for semaglutide, $289– for tirzepatide depending on tier) is transparent and predictable—your dose may increase, but your price doesn't. Many patients with high-deductible or specialty pharmacy copays pay $200+ per month out of pocket. PlexusDx eliminates insurance barriers entirely while remaining HSA/FSA eligible.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.